Columns & Departments
Eminent Domain Law
A case in which there were no consequential damages for taking of temporary easement.
Features
Note from Your Editor
As our world continues to "dance as fast as it can," legal marketers around the globe continue to struggle with educating their lawyers in the ways of the "new normal."
Columns & Departments
Verdicts
In-depth look at a ruling that a plaintiff was not unfairly surprised by greater detail In expert testimony .
Columns & Departments
In the Marketplace
Who's doing what; who's going where.
Legal Sector Jobs Hold Steady in November
The number of jobs in the legal sector remained flat in November compared with the previous month, even as the total number of jobs in the U.S. increased by 321,000, according to seasonally adjusted preliminary data released last month by the U.S. Bureau of Labor Statistics.
Drug & Device News
Updated information about a key case involving contaminated medication.
Features
<b><i>Leadership</i></b>: Hidden Business Development Opportunities
These days, all firms must provide more value-added services. In the short run, the more you know the better chance you have at winning the business. In the long run, close client knowledge and an understanding of the marketplace will augment client retention.
Quarterly State Compliance Review
This edition of the Quarterly State Compliance Review looks at some legislation of interest to corporate lawyers that went into effect during the last quarter. It also examines some recent decisions of interest, including three from Delaware.
Features
Georgia Fed. Ct. Dismisses Suit Over <i>Honey</i> Films
The U.S. District Court for the Northern District of Georgia, Atlanta Division, dismissed a lawsuit brought by hip-hop dancer Ereina "Honey Rockwell" Valencia over Universal's <i>Honey</i> and <i>Honey 2</i> movies, released respectively in 2003 and 2011.
Features
Discovery Sanctions In Litigation over Soap Opera
A copyright infringement lawsuit centered on the Telemundo network's popular Spanish-language telenovela <i>El Rostro de Analia</i> has some melodrama of its own.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Law Firms and the Rise of HospitalityThe law firm office cannot remain unchanged, as if frozen in time set to some date prior to the onset of pandemic, when the terms and meaning have all changed. In fact, the office must now provide benefits or an experience the lawyers and staff cannot get at home.Read More ›
- The DOJ's Corporate Enforcement Policy: One Year LaterThe DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.Read More ›
- Lack of Logo Placement At Center of Ruling Over Meat Loaf Album PackagingTo build visibility for its brand, a record label or production company will want its logo included on products containing its master recordings manufactured and distributed by third parties. This will be addressed in the agreement between the label or production company and manufacturer/distributor. The failure to include the logo may raise a host of issues, from the breadth of the logo-placement obligation ' such as whether it includes Internet downloads ' to the proper theory on which to base any damages and just which album-sales figures are subject to evidentiary discovery. A recent ruling by the U.S. Court of Appeals for the Sixth Circuit ' in a long-running dispute between Cleveland International Records and Sony Music Entertainment ' illustrated how these issues may be argued and decided.Read More ›
- From the PTO to the FDA: What to Consider When Branding Clinical TrialsThe legal implications of branding generally arise initially for companies during the process of selecting a company name and any initial product or service names. For drug development companies, however, careful consideration should also be paid to the implications of branding a clinical trial.Read More ›